bw-755c has been researched along with 4-bromophenacyl bromide in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, T; Hashizume, T; Sato, T | 1 |
| Abrahams, C; Garland, A; Leff, AR; Strek, ME; White, SR | 1 |
| Beraud, M; Cambon, C; Didier, A; Forgue, MF; Pinelli, E; Pipy, B; Souqual, MC; Vandaele, J | 1 |
| Kojima, I; Kojima, K; Rasmussen, H | 1 |
| Kato, R; Kumakura, K; Sasakawa, N; Yamamoto, S | 1 |
| Geertsma, MF; Nibbering, PH; Van Den Barselaar, MT; Van Furth, R; Zheng, L; Zomerdijk, TP | 1 |
6 other study(ies) available for bw-755c and 4-bromophenacyl bromide
| Article | Year |
|---|---|
Preferential activation of phospholipase A2 by low concentrations of phosphatidic acid with long-chain fatty acids in rabbit platelets.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Acetophenones; Animals; Blood Platelets; Cytosol; Enzyme Activation; Kinetics; Phosphatidic Acids; Phospholipases A; Phospholipases A2; Platelet Aggregation; Quinacrine; Rabbits | 1992 |
Direct effects and augmentation of airway smooth muscle contraction caused by phospholipase A2.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Acetophenones; Acetylcholine; Animals; Bronchial Hyperreactivity; Dose-Response Relationship, Drug; Eicosanoids; Guinea Pigs; Male; Muscle Contraction; Muscle, Smooth; Phospholipases A; Phospholipases A2; Receptors, Muscarinic; Trachea | 1992 |
Possible implication of arachidonic acid metabolism in the decrease of chemiluminescence production after exposure of murine peritoneal macrophages to diethylnitrosamine and tumour promoter, 12-O-tetradecanoylphorbol-13-acetate.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Acetophenones; Alkaloids; Animals; Arachidonic Acid; Arachidonic Acids; Cell Membrane; Cell Survival; Culture Media; Cyclooxygenase Inhibitors; Diethylnitrosamine; Dose-Response Relationship, Drug; Extracellular Space; Female; Indomethacin; Intracellular Fluid; Isoquinolines; Kinetics; Leukotrienes; Luminescent Measurements; Macrophage Activation; Macrophages; Mice; Oxygen; Peritoneal Cavity; Phospholipids; Piperazines; Prostaglandins; Protein Kinase C; Staurosporine; Tetradecanoylphorbol Acetate; Tritium | 1991 |
Possible role of phospholipase A2 action and arachidonic acid metabolism in angiotensin II-mediated aldosterone secretion.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; 5,8,11,14-Eicosatetraynoic Acid; Acetophenones; Aldosterone; Angiotensin II; Animals; Arachidonic Acid; Arachidonic Acids; Caffeic Acids; Calcium; Cattle; Cyclooxygenase Inhibitors; Dantrolene; Dose-Response Relationship, Drug; Indomethacin; Lipoxygenase Inhibitors; Phospholipases; Phospholipases A; Phospholipases A2; Pyrazoles; Quinacrine | 1985 |
Prevention of catecholamine release from adrenal chromaffin cells by phospholipase A2- and lipoxygenase-inhibitors.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Acetophenones; Adrenal Medulla; Animals; Arachidonic Acids; Aspirin; Catecholamines; Cattle; Chromaffin System; In Vitro Techniques; Lipoxygenase Inhibitors; Phospholipases; Phospholipases A; Phospholipases A2; Pyrazoles; Quinacrine | 1983 |
Arachidonic acid, but not its metabolites, is essential for FcgammaR-stimulated intracellular killing of Staphylococcus aureus by human monocytes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Acetophenones; Arachidonic Acid; Calcium-Calmodulin-Dependent Protein Kinases; Cyclic AMP-Dependent Protein Kinases; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Genistein; Humans; Immunoglobulin G; Indomethacin; Lipoxygenase Inhibitors; Monocytes; Oxygen; Phagocytosis; Phospholipases A; Phospholipases A2; Protein Kinase C; Protein-Tyrosine Kinases; Receptors, IgG; Staphylococcus aureus; Sulfonamides | 1999 |